Research location
Waterloo
Ontario, Canada
Advertisement
Research activity in Waterloo
Ontario, CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 92 trials and 96 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Waterloo
92 linked trials · page 1 of 2Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision ImpairmentNCT07341763 · 2026-07-01 · 1 site observation
RECRUITING
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation
RECRUITING
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeNCT07190209 · 2025-09-16 · 1 site observation
RECRUITING
An Evaluation of Dose-escalation for Intrathoracic TumoursNCT06794125 · 2025-09-03 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartNCT06935370 · 2025-05-20 · 1 site observation
RECRUITING
Comorbidity Management in Rheumatic Disease.NCT06579222 · 2025-05-01 · 1 site observation
RECRUITING
Validation and Testing of a Novel Continuous Glucose and Continuous Ketone Monitoring Device in Healthy VolunteersNCT06877975 · 2025-03-30 · 1 site observation
RECRUITING
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation
RECRUITING
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionNCT06307652 · 2024-04-12 · 1 site observation
RECRUITING
Comprehensive Assessment of Neurodegeneration and DementiaNCT03402919 · 2016-06-01 · 1 site observation
RECRUITING
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.NCT07222917 · 2025-12-05 · 1 site observation
ACTIVE_NOT_RECRUITING
The Electronic Asthma Management System in PharmaciesNCT07038642 · 2025-06-23 · 1 site observation
ENROLLING_BY_INVITATION
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationNCT06200207 · 2024-04-01 · 2 site observations
ACTIVE_NOT_RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.NCT06268873 · 2024-03-29 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant HypertensionNCT06168409 · 2024-03-01 · 1 site observation
COMPLETED
A Study of the Efficacy of IAMT as an Assessment Tool for Prediction of Progression of Parkinson's DiseaseNCT05971459 · 2024-01-15 · 1 site observation
UNKNOWN
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose WeightNCT06066528 · 2023-11-27 · 1 site observation
COMPLETED
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightNCT06066515 · 2023-11-25 · 1 site observation
COMPLETED
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionNCT06034743 · 2023-11-22 · 1 site observation
COMPLETED
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)NCT06077864 · 2023-11-20 · 1 site observation
COMPLETED
Study of INV-202 in Patients With Obesity and Metabolic SyndromeNCT05891834 · 2023-09-08 · 2 site observations
COMPLETED
A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNCT05936151 · 2023-07-20 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe AsthmaNCT05851443 · 2023-07-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and InflammationNCT05636176 · 2023-05-08 · 2 site observations
TERMINATED
A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)NCT05592275 · 2023-02-03 · 1 site observation
TERMINATED
Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE StudyNCT05384431 · 2022-08-15 · 1 site observation
COMPLETED
A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 DiabetesNCT05254002 · 2022-06-23 · 2 site observations
COMPLETED
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First TimeNCT05362058 · 2022-06-03 · 1 site observation
COMPLETED
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe AsthmaNCT05104892 · 2021-12-12 · 1 site observation
COMPLETED
Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)NCT04968184 · 2021-11-05 · 1 site observation
TERMINATED
Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%NCT04986202 · 2021-06-30 · 1 site observation
COMPLETED
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney DiseaseNCT04750577 · 2021-04-27 · 1 site observation
COMPLETED
A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes MellitusNCT04515849 · 2020-08-31 · 1 site observation
COMPLETED
Early Psychosis Intervention - Spreading Evidence-based TreatmentNCT03919760 · 2020-01-03 · 1 site observation
COMPLETED
Comparing the Effects of Instability Resistance Training Versus Aerobic Training on Cognitive and Motor Improvements Found in Parkinson's Disease ParticipantsNCT03711955 · 2019-02-18 · 1 site observation
UNKNOWN
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With AsthmaNCT03769090 · 2018-12-13 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskNCT03730662 · 2018-11-20 · 1 site observation
COMPLETED
Rock Steady Boxing vs. Sensory Attention Focused ExerciseNCT03618901 · 2018-09-30 · 1 site observation
UNKNOWN
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.NCT03619213 · 2018-08-27 · 1 site observation
COMPLETED
A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its SafetyNCT03541174 · 2018-06-18 · 1 site observation
COMPLETED
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.NCT03448406 · 2018-03-20 · 1 site observation
COMPLETED
This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure SymptomsNCT03448419 · 2018-03-20 · 1 site observation
COMPLETED
Virtual Reality Can be Used to Improve Balance Reducing Dynamic Falls in Those With Parkinson's DiseaseNCT03406728 · 2018-01-21 · 1 site observation
UNKNOWN
Clinical Investigation on the Safety of Avocado Pulp LipidsNCT03898505 · 2017-11-24 · 1 site observation
COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes MellitusNCT03086330 · 2017-03-15 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)NCT03057977 · 2017-03-06 · 1 site observation
COMPLETED
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)NCT03057951 · 2017-03-02 · 1 site observation
COMPLETED
Investigating Therapies for Freezing of GaitNCT03065127 · 2017-02-24 · 1 site observation
UNKNOWN
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart FailureNCT03036124 · 2017-02-08 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.